Inside M3 Insights is brand new for M3 Global Research.
In response to feedback from our panellists this section is where we share findings from M3 Global Research studies as well as insights from across the M3 Group including Doctors.net.uk and M3 Medical.
Each year we conduct over 3,000 studies in conjunction with over 370.000 healthcare professionals worldwide. We think it’s important that we share the outputs of some of those studies with the community.
Our goal is to demonstrate how our research studies positively impact the healthcare industry and how vital your participation is. We also hope that within the findings you’ll find information that informs your clinical practice and supports continuing medical education.
We hope you will find this section useful and interesting. You can access our last two Inside M3 Insights below. Your professional opinion is important to us, we are looking forward to hearing your feedback.
In April we surveyed 3114 people in the United States and asked them about their perceptions of their current health and wellness. The purpose was understanding what our participants thought were the most important wellness areas and popular ways people keep…
Welcome to the October edition of ‘Inside M3 Insights’! This month, we are sharing the results of one insider survey carried out by MDLinx, with nearly 900 physicians and advanced practice clinicians in the United States. The purpose of this…
The study we are sharing this month is about fatigue at work. Conducted by Doctors.net.uk and M3 Global Research, the study involved 799 respondents and was carried out after previous research into the impact of fatigue on driving home after night…
This study was centred around continuing medical education for both secondary and primary care doctors and asked what role the pharmaceutical industry should play. It aimed to answer the following question: Are doctors getting what they need? Over 1,500 European…
The study “GP awareness about chemoprevention” was carried out on behalf of Cancer Research UK, and aimed to specifically explore GP awareness on tamoxifen and aspirin use with breast and bowel cancers. The survey took place in May 2016 in…
